Twenty-four Suffolk lambs (average BW 38 +/- 2.7 kg; 16 ewes and 8 wethers) were fed either a corn-cottonseed hull-based control diet (CON) or CON plus 250 ppb of Cr as chromium tripicolinate (CrPic). Lambs were penned in groups of three and ADG and DMI were measured through d 85 of the experiment. Jugular blood samples were obtained during wk 2, 7, and 11. An i.v. glucose tolerance test (IVGTT; 500 mg of glucose/kg BW) and an i.v. insulin challenge test (IVICT; .1 IU of ovine insulin/kg BW) were performed during wk 2 and 10 of the trial. This was followed by a N balance trial during wk 3 and 11. Wethers were slaughtered at the end of the experiment and carcass characteristics determined. No differences (P > .10) were observed between dietary treatments in DMI, ADG, or N balance; however, the CrPic-fed wethers had 18% less fat over the 10th rib (P = .082) and a lower yield grade (P = .014). Plasma NEFA was lower throughout the trial (P < .03) and cholesterol was 17% lower during wk 2 (P < .02) in lambs fed CrPic. There were no differences due to diet (P > .10) in plasma concentrations of urea N, glucose, albumin, total protein, insulin, glucagon, triiodothyronine, or thyroxine. Glucose clearance rate and half-life during the IVGTT and IVICT did not differ (P > .10) between CON and CrPic groups; however, during the IVGTT on wk 2, plasma insulin was elevated (P < .05) and glucose reduced (P = .067) in the lambs fed CrPic. Supplemental CrPic seems to influence metabolic measurements that may affect performance of growing lambs.
Holstein calves, 10 steers (98 +/- 16 kg; Exp. 1) and 14 heifers (122 +/- 7 kg; Exp. 2), were fed either corn-cottonseed hull basal diets (CON; 15.1 and 13.2% CP, respectively) or CON plus 370 micrograms/kg of Cr as Cr-tripicolinate (CrP). After either 58 (Exp. 1) or 56 (Exp. 2) days of ADG and DMI measurement, calves were individually fed 1.4% of their BW every 12 h through the end of each experiment. Nitrogen balance, i.v. glucose tolerance tests (IVGTT), i.v. insulin challenge tests (IVICT), baseline growth hormone (GH) measurements, and GH-releasing hormone challenges were then performed on calves in split groups on d 70 through 87 in Exp. 1. In Exp. 2, all challenges began on d 78 and N balance was not determined. Inclusion of CrP did not affect (P > .10) ADG, DMI, or ADG/DMI of pooled data from Exp. 1 and 2 or N balance criteria in Exp. 1. Plasma glucose, insulin, and NEFA concentrations were not affected (P > .10) by CrP. Total plasma cholesterol was lower (P < .05) for CrP- than for CON-fed calves at wk 4 in Exp. 1 and wk 6 in Exp. 2. During IVGTT, calves fed CrP vs CON had higher (P < .05) clearance rates for glucose in Exp. 1 (2.68 vs 1.88%/min) and in Exp. 2 (2.64 vs 2.08%/min). During IVICT, calves fed CrP vs CON had higher clearance rates for glucose in Exp. 1 (2.98 vs 2.34%/min; P = .12) and in Exp. 2 (2.89 vs 2.00%/min; P < .05).(ABSTRACT TRUNCATED AT 250 WORDS)
Two experiments were conducted to evaluate the effect of Cr as Cr tripicolinate (CrPic) on growth, glucose tolerance, insulin sensitivity, plasma metabolites, and growth hormone (GH) in pigs. Pigs were fed a control diet or a diet supplemented with 200 micrograms of Cr/kg of diet as CrPic. Thirty (15 per diet, initial BW was 21.3 kg) and 24 (12 per diet, initial BW was 24.9 kg) crossbred barrows were used in Exp. 1 and 2, respectively. The diets were formulated to provide 120% of the lysine requirement for 20- to 50-kg pigs. A glucose tolerance test (IVGTT; 500 mg of glucose/kg BW) and an insulin challenge test (IVICT; .1 IU of porcine insulin/kg BW) were conducted. In addition, during Exp. 1, a GH-releasing hormone (GHRH) challenge was conducted. All data were pooled across experiments, except where noted. Average daily gain, ADFI, gain/feed, and fasting (15 to 18 h) plasma glucose and total protein concentrations were not affected (P > .10) by dietary treatment. Fasting plasma cholesterol (P < .05) was increased and NEFA (Exp. 2 only, P < .02), urea N (P < .07), and insulin (P < .10) concentrations were decreased in pigs fed CrPic. During the IVGTT and IVICT, glucose disappearance rate (k, percentage/minute) was increased (P < .04) and glucose half-life (t1/2, minutes) was decreased (P < .04) in pigs fed CrPic; however, insulin kinetics were not altered (P > .10). During the GHRH challenge, pigs fed CrPic had decreased (P < .09) area under the response curve for GH.(ABSTRACT TRUNCATED AT 250 WORDS)
Eighteen Holstein (experiment 1) and 15 Jersey (experiment 2) heifer calves were fed milk replacer once or twice daily to determine effects of feeding frequency on weight gain, starter intake, and glucose metabolism. Body weights were measured weekly from birth to 8 wk. Blood samples were collected at wk 1 through 6 from all calves before and at 30, 60, 90, 120 and 180 min after the morning feeding. Plasma was analyzed for glucose, insulin, glucagon, and nonesterified fatty acids (NEFA). Urine was collected 90 min postfeeding to measure glucose concentration. Treatment did not affect mean starter intake or body weight. In experiments 1 and 2 mean plasma glucagon, glucose, NEFA, and insulin and urinary glucose concentrations were not affected by treatment. There was an interaction of sampling time and treatment for plasma insulin concentrations but not for glucose concentrations in both experiments. Following feeding, calves fed milk replacer once daily had higher insulin concentrations than those fed twice daily. There was an interaction of sampling time and treatment for plasma NEFA concentrations in Jersey calves only. Jersey calves fed milk replacer once daily had higher plasma NEFA concentrations before the morning milk replacer feeding. At wk 3 and 6, frequently sampled intravenous glucose tolerance tests were performed to assess glucose effectiveness, insulin sensitivity, and acute insulin response. In experiments 1 and 2 glucose effectiveness and insulin sensitivity were similar regardless of milk replacer feeding frequency. In Holstein and Jersey calves fed milk replacer twice daily, acute insulin response was greater than in calves fed once daily. However, insulin sensitivity decreased with age, while acute insulin response increased with age. These data suggest that feeding calves milk replacer once daily did not deleteriously affect performance or glucose metabolism regardless of breed.
Two experiments were conducted to study the effect of intake of fiber on productive performance of high producing dairy goats during early to midlactation. Four dietary treatments were isonitrogenous and consisted of combinations of chopped alfalfa hay and concentrate, yielding 14, 18, 22, and 26% ADF. In Experiment 1, 40 multiparous Alpine does were used in a completely randomized block design. Milk fat content and total chewing time increased, and milk yield tended to decrease, as dietary ADF intake increased. Chewing efficiency [min/(g x kg BW.75)] for DM decreased, whereas that for ADF increased as ADF intake increased. Prediction equations were the following: milk fat yield, g/d = 115.78 - .128 x ADF intake, g/d + .00021 X (ADF intake)2 (r = .55); total chewing time, min/d = 345.33 + .32 x ADF intake, g/d (r = .60). In Experiment 2, 20 does were used in a completely randomized design. Apparent digestibilities of DM and energy decreased as dietary ADF intake increased. Rumen turnover rate and transit time of liquid were affected by ADF intake. Transit time of hay decreased as ADF intake increased. Intake of ADF affected pH and ammonia, acetate, and butyrate concentrations in the rumen. Acetate to propionate ration increased with ADF intake. No apparent trends were observed in whole blood beta-hydroxybutyrate or in plasma NEFA concentrations related to ADF intake. It appeared that DMI and milk fat yield leveled at 22% ADF or 43% NDF. For lactating dairy goats producing more than 3.5 kg/d of milk, calculated fat output reached a plateau when they consumed 587 g/d of ADF and spent 512 min/d chewing.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.